Sign in

Back to the bill

89th General Assembly · Funnel one-pager · Monday, November 9, 2026

SF 2157: Relating to medical cannabidiol by providing deductions from the individual and corporate income taxes for expenses incurred by medical cannabidiol manufacturers and dispensaries, and exempting the sale of medical cannabidiol products from the sales and use tax, and including retroactive applicability provisions

Died when the session ended · The General Assembly adjourned on May 24, 2022. Bills that didn’t pass both chambers died.

What it does

DIVISION I. Under federal law, a medical cannabidiol manufacturer and a medical cannabidiol dispensary are prohibited from taking business expense deductions by section 280E of the Internal Revenue Code. Currently, Iowa computes individual net income and corporate taxable income based upon federal income calculations, and therefore Iowa currently prohibits a medical cannabidiol manufacturer and a medical cannabidiol dispensary from taking business expense deductions as well because the deductions are not allowed at the federal level.

Sponsors

Not listed

Cost

No fiscal note

Senate subcommittee · named February 2, 2022

  • Sen. Dan Dawson (R) · dan.dawson@legis.iowa.gov
  • Sen. Joe Bolkcom (D)
  • Sen. Tim Goodwin (R)

Lobbying · 4 for, 0 against

For: Green Leaf Cannabis Co.; Iowa Cannabis Company; Iowans for Medical Marijuana; MedPharm Iowa

In plain words

  1. February 1, 2022Filed in the Senate and sent to the Ways and Means committee
  2. February 2, 2022Senate subcommittee named: Dawson, Bolkcom and Goodwin

From public records at legis.iowa.gov, compiled by Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Monday, November 9, 2026. https://iowafunnel.com/bills/89/SF2157